ASBP · Company research

Aspire-Lakewood Holdings, Inc. Common Stock (ASBP): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

17records availableHealthcare

Stock News & Events data

Database-backed records only

17 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
(ASBP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily(ASBP) Movement Within Algorithmic Entry Frameworks Stock Traders DailyView source ↗Stock Traders DailyOct 7, 2026neutral00.6
Understanding Momentum Shifts in (ASBP) - Stock Traders DailyUnderstanding Momentum Shifts in (ASBP) Stock Traders DailyView source ↗Stock Traders DailySep 27, 2026neutral00.6
Aspire-Lakewood Launches $10 Million Share Repurchase Program - The Globe and MailAspire-Lakewood Launches $10 Million Share Repurchase Program The Globe and MailView source ↗The Globe and MailSep 10, 2026neutral00.6
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal - Yahoo FinanceEXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal Yahoo FinanceView source ↗Yahoo FinanceAug 10, 2026neutral00.6
Aspire Bi clarifies public warrant terms after two reverse stock splits; exercise price now $13,800 - TradingViewAspire Bi clarifies public warrant terms after two reverse stock splits; exercise price now $13,800 TradingViewView source ↗TradingViewJul 20, 2026neutral00.6
Aspire Biopharma puts 50 mg caffeine stick packs on Amazon - Stock TitanAspire Biopharma puts 50 mg caffeine stick packs on Amazon Stock TitanView source ↗Stock TitanJun 24, 2026neutral00.6
ASBP Falls As Aspire Biopharma Bets $30M On Auto Deal - Timothy SykesASBP Falls As Aspire Biopharma Bets $30M On Auto Deal Timothy SykesView source ↗Timothy SykesJun 14, 2026neutral00.6
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Yahoo FinanceASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? Yahoo FinanceView source ↗Yahoo FinanceJun 12, 2026neutral00.6
ASBP Stock Draws Trader Focus As Volatility Spikes - StocksToTradeASBP Stock Draws Trader Focus As Volatility Spikes StocksToTradeView source ↗StocksToTradeJun 12, 2026neutral00.6
Aspire Biopharma Stock Chops After Volatile Spike - StocksToTradeAspire Biopharma Stock Chops After Volatile Spike StocksToTradeView source ↗StocksToTradeJun 12, 2026neutral00.6
ASBP Jumps As Aspire Biopharma Attracts High-Volume Trading - Timothy SykesASBP Jumps As Aspire Biopharma Attracts High-Volume Trading Timothy SykesView source ↗Timothy SykesJun 12, 2026neutral00.6
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - StocktwitsASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? StocktwitsView source ↗StocktwitsJun 12, 2026neutral00.6
Which stocks are moving before the opening bell on Thursday? - ChartMillWhich stocks are moving before the opening bell on Thursday? ChartMillView source ↗ChartMillMay 7, 2026neutral00.6
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio - Yahoo FinanceAspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio Yahoo FinanceView source ↗Yahoo FinanceMay 7, 2026neutral00.6
Aspire Biopharma Announces $5.0 Million Share Repurchase Program - Yahoo FinanceAspire Biopharma Announces $5.0 Million Share Repurchase Program Yahoo FinanceView source ↗Yahoo FinanceApr 27, 2026neutral00.6
ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - StocktwitsASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback StocktwitsView source ↗StocktwitsApr 21, 2026neutral00.6
These stocks are moving in today's session - ChartMillThese stocks are moving in today's session ChartMillView source ↗ChartMillApr 15, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.